Thoroughbred Financial Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Thoroughbred Financial Services's AZN Position: Q3 2026 in Review
Thoroughbred Financial Services reduced its AstraZeneca (AZN) stake by 34% in Q3 2026, selling an estimated $241K and leaving 2,756 shares worth $445K. The position accounts for 0.02% of the portfolio, ranked #461.
Thoroughbred Financial Services first reported a position in AZN in Q4 2022 and has held it in 16 quarters since. The position peaked at $2.36M in Q4 2023. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Thoroughbred Financial Services held 2,756 shares of AstraZeneca worth $445K as of Q3 2026.
- Thoroughbred Financial Services sold 1,446 AstraZeneca shares in Q3 2026, an estimated $241K.
- AstraZeneca made up 0.02% of Thoroughbred Financial Services's portfolio in Q3 2026, its #461 holding.
- Thoroughbred Financial Services first reported a position in AstraZeneca in Q4 2022 and has held it in 16 quarters since.
- Thoroughbred Financial Services's AstraZeneca position peaked at $2.36M in Q4 2023.
- 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Thoroughbred Financial Services's 13F filing for Q3 2026, filed 9 Nov 2026.